Changes in entropy on polarized-sensitive optical coherence tomography images after therapeutic subthreshold micropulse laser for diabetic macular edema: A pilot study
- PMID: 34516553
- PMCID: PMC8437304
- DOI: 10.1371/journal.pone.0257000
Changes in entropy on polarized-sensitive optical coherence tomography images after therapeutic subthreshold micropulse laser for diabetic macular edema: A pilot study
Abstract
Purpose: To investigate the dynamics of the healing process after therapeutic subthreshold micropulse laser (SMPL) for diabetic macular edema (DME) using polarization-sensitive optical coherence tomography (PS-OCT).
Methods: Patients with treatment-native or previously-treated DME were prospectively imaged using PS-OCT at baseline, 1, 2, 3, and 6 months. The following outcomes were evaluated: changes in the entropy value per unit area (pixel2) in the retinal pigment epithelium (RPE) on the B-scan image; changes in the entropy value in each stratified layer (retina, RPE, choroid) based on the ETDRS grid circle overlaid with en face entropy mapping, not only the whole ETDRS grid area but also a sector irradiated by the SMPL; and the relationship between edema reduction and entropy changes.
Results: A total of 11 eyes of 11 consecutive DME patients were enrolled. No visible signs of SMPL treatment were detected on PS-OCT images. The entropy value per unit area (pixel2) in the RPE tended to decrease at 3 and 6 months from baseline (35.8 ± 17.0 vs 26.1 ± 9.8, P = 0.14; vs 28.2 ± 18.3, P = 0.14). Based on the en face entropy mapping, the overall entropy value did not change in each layer in the whole ETDRS grid; however, decrease of entropy in the RPE was observed at 2, 3, and 6 months post-treatment within the SMPL-irradiated sectors (P < 0.01, each). There was a positive correlation between the change rate of retinal thickness and that of entropy in the RPE within the SMPL-irradiated sector at 6 months (r2 = 0.19, P = 0.039).
Conclusion: Entropy measured using PS-OCT may be a new parameter that facilitates objective monitoring of SMPL-induced functional changes in the RPE that could not previously be assessed directly. This may contribute to a more promising therapeutic evaluation of DME.
Clinical trial: This clinical study was registered in UMIN-CTR (ID: UMIN000042420).
Conflict of interest statement
MY is an inventor of patents, whose applicant and assignee are Tomey Corporation, in the following; JP 6463051 B2, US 9593936 B2, and EP 2995245 B1, which partly cover the interferometer of PS-OCT; JP 6542178 B2, US 2018/0035894 A1, and EP 3278720 B1, which partly cover the signal processing of PS-OCT. PS-OCT used in this study is related to products in development by Tomey Corporation. Tomey Corporation is a sales distributor of the micropulse laser (IQ 577; Iridex Corporation, Mountain View, CA, USA) in Japan. Three TOMEY staff members were only involved in confirming the content of this paper on the principle of PS-OCT, and were not involved in any funding or other activities. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Figures








References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources